Skip to content

Arbutus Biopharma Corporation ABUS Business Segments — Other segment expense

Similar metrics at other companies

Lexicon Pharmaceuticals logo
LXRXReportable Segment — Other segment expense
$3.08M+9.9%
Arcutis Biotherapeutics, Inc. logo
ARQTReportable Segment — Other segment expenses
$5.86M-18.4%
Hyliion logo
HYLNReportable Segment — Other operating expense
$300K0.0%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Other segment expenses
$5000.0%
GRAIL, Inc. logo
GRALReportable Segment — Other segment expenses
$9.43M-50.6%
Biogen logo
BIIBReportable Segment — Other segment expense
$317M-10.4%

Other financials

Income statement

See full
Revenue$179.1M+10,055%
Operating income$168.9M+757%
Net income$169.7M+792%
EPS (diluted)$0.87+769%

Balance sheet

See full
Cash & equivalents$23.7M-36.1%
Total debt$631.0K-46.9%
Total equity$260.2M+229%
Total assets$277.2M+137%

Cash flow

See full
Operating cash flow-$8.1M+39.4%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$881.02M+34.1%
Enterprise value$857.94M+38.1%
P/E5.5×
P/S4.6×-98.0×

Profitability

See full
Operating margin81.7%+42.1pp
Net margin84%+43.4pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity94.7%+65.1pp
Debt / equity0.0×
Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept abus:OtherSegmentExpense.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's business segments — other segment expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arbutus Biopharma Corporation's business segments — other segment expense?
Arbutus Biopharma Corporation (ABUS) reported business segments — other segment expense of $237K in Q1 2026.
How has Arbutus Biopharma Corporation's business segments — other segment expense changed year-over-year?
Arbutus Biopharma Corporation's business segments — other segment expense decreased by 26.6% year-over-year, from $323K to $237K.
What is the long-term trend for Arbutus Biopharma Corporation's business segments — other segment expense?
Over 2 years (2023 to 2025), Arbutus Biopharma Corporation's business segments — other segment expense has grown at a 86.4% compound annual growth rate (CAGR), from $503K to -$1.75M.
What does business segments — other segment expense mean?
This category captures miscellaneous operational expenses within the segment that do not fall under specific R&D or administrative classifications. It is used to reconcile the segment's total operating costs.